Microbio Co., Ltd.
Research Microbio Co., Ltd. (4128.TWO) on Bullrun: market cap TWD 9.12B, P/E 17.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4128.TWO
- ExchangeTWO
- CountryTaiwan
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyTWD
- Market capTWD 9.12B
- P/E17.4
- Financial periodQ2 2026
- RevenueTWD 479.28M
- Net incomeTWD 832.31M
- Free cash flow-TWD 397.44M
- Gross margin37.8%
Valuation Snapshot
latest market cap is TWD 9.12B; P/E is 17.4.
Peer valuation comparison
Latest P/E is 17.42x versus a Consumer Defensive sector median of 16.8x (3.7% above).
Latest P/E is 17.42x versus a Taiwan median of 18.67x (6.7% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 9.12B | 17.4 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Microbio Co., Ltd.
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of technology development, transfer, and consulting services;
ETFs that hold Microbio Co., Ltd.
US-listed ETFs
Microbio Co., Ltd. is held by 15 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Microbio Co., Ltd.'s market cap?
Microbio Co., Ltd.'s market capitalization is TWD 9.12B.
What is Microbio Co., Ltd.'s P/E ratio?
Microbio Co., Ltd.'s price-to-earnings (P/E) ratio is 17.4.
What does Microbio Co., Ltd. do?
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of technology development, transfer, and consulting services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd.